The pharmacy, healthcare provider, and retailer said its 2015 adjusted earnings per share is expected to be in the range of $5.05 to $5.19, a 12.5% to 15.75% increase over the previous year.
Shares of CVS Health are up by 0.26% to $90.10 in pre-market trading this morning.
"We've established a solid track record of delivering on our promises, and our results prove that out. Looking ahead, we are targeting solid, long term enterprise growth and expect to generate a significant amount of cash that will be available to enhance returns," said CVS executive vice president and CFO Dave Denton.
Additionally, CVS Health announced a 27% increase to its quarterly dividend, to 35 cents per share of common stock. The company also announced the approval of a new $10 billion share repurchase program, relating to CVS Health's outstanding stock.
Separately, TheStreet Ratings team rates CVS HEALTH CORP as a Buy with a ratings score of A+. TheStreet Ratings Team has this to say about their recommendation:
"We rate CVS HEALTH CORP (CVS) a BUY. This is based on the convergence of positive investment measures, which should help this stock outperform the majority of stocks that we rate. The company's strengths can be seen in multiple areas, such as its revenue growth, solid stock price performance, largely solid financial position with reasonable debt levels by most measures and notable return on equity. We feel these strengths outweigh the fact that the company has had sub par growth in net income."